Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.

Evan Cantor; Kyle Wierzbicki; Rohinton Tarapore; Chase Thomas; Rodrigo Cartaxo; Viveka Nand Yadav; Ramya Ravindran; Amy Bruzek; Andrea Franson; Rajen Mody; Hugh Garton; Yazmin Odia; Cassie Kline; Nicholas A Vitanza; Soumen Khatua; Sabine Mueller; Joshua E. Allen; Sharon L. Gardner; Carl Johannes Koschmann

doi:10.1200/JCO.2021.39.15_SUPPL.2012

Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.

Evan Cantor
, Kyle Wierzbicki
, Rohinton Tarapore
, Chase Thomas
, Rodrigo Cartaxo
, Viveka Nand Yadav
, Ramya Ravindran
, Amy Bruzek
, Andrea Franson
, Rajen Mody
, Hugh Garton
, Yazmin Odia
, Cassie Kline
, Nicholas A Vitanza
, Soumen Khatua
, Sabine Mueller
, Joshua E. Allen
, Sharon L. Gardner
, Carl Johannes Koschmann

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	39
DOIs	https://doi.org/10.1200/JCO.2021.39.15_SUPPL.2012
State	Published - May 28 2021

Disciplines

Medicine and Health Sciences
Oncology

Access to Document

10.1200/JCO.2021.39.15_SUPPL.2012License: Unspecified

Cite this

Cantor, E., Wierzbicki, K., Tarapore, R., Thomas, C., Cartaxo, R., Yadav, V. N., Ravindran, R., Bruzek, A., Franson, A., Mody, R., Garton, H., Odia, Y., Kline, C., Vitanza, N. A., Khatua, S., Mueller, S., Allen, J. E., Gardner, S. L., & Koschmann, C. J. (2021). Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201. Journal of Clinical Oncology, 39. https://doi.org/10.1200/JCO.2021.39.15_SUPPL.2012

Cantor, E, Wierzbicki, K, Tarapore, R, Thomas, C, Cartaxo, R, Yadav, VN, Ravindran, R, Bruzek, A, Franson, A, Mody, R, Garton, H, Odia, Y, Kline, C, Vitanza, NA, Khatua, S, Mueller, S, Allen, JE, Gardner, SL & Koschmann, CJ 2021, 'Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.', Journal of Clinical Oncology, vol. 39. https://doi.org/10.1200/JCO.2021.39.15_SUPPL.2012

@article{4871f272ffa8437faaf9c7f40e8ada43,

title = "Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.",

author = "Evan Cantor and Kyle Wierzbicki and Rohinton Tarapore and Chase Thomas and Rodrigo Cartaxo and Yadav, \{Viveka Nand\} and Ramya Ravindran and Amy Bruzek and Andrea Franson and Rajen Mody and Hugh Garton and Yazmin Odia and Cassie Kline and Vitanza, \{Nicholas A\} and Soumen Khatua and Sabine Mueller and Allen, \{Joshua E.\} and Gardner, \{Sharon L.\} and Koschmann, \{Carl Johannes\}",

note = "2012 Background: Diffuse midline glioma (DMG) with the H3K27M mutation is a lethal childhood brain cancer, with patients rarely surviving 2 years from diagnosis. There are few available means of monitoring the disease beyond serial MRI scans, making clinical decision making slow, difficult, and often reactive.",

year = "2021",

month = may,

day = "28",

doi = "10.1200/JCO.2021.39.15\_SUPPL.2012",

language = "American English",

volume = "39",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.

AU - Cantor, Evan

AU - Wierzbicki, Kyle

AU - Tarapore, Rohinton

AU - Thomas, Chase

AU - Cartaxo, Rodrigo

AU - Yadav, Viveka Nand

AU - Ravindran, Ramya

AU - Bruzek, Amy

AU - Franson, Andrea

AU - Mody, Rajen

AU - Garton, Hugh

AU - Odia, Yazmin

AU - Kline, Cassie

AU - Vitanza, Nicholas A

AU - Khatua, Soumen

AU - Mueller, Sabine

AU - Allen, Joshua E.

AU - Gardner, Sharon L.

AU - Koschmann, Carl Johannes

N1 - 2012 Background: Diffuse midline glioma (DMG) with the H3K27M mutation is a lethal childhood brain cancer, with patients rarely surviving 2 years from diagnosis. There are few available means of monitoring the disease beyond serial MRI scans, making clinical decision making slow, difficult, and often reactive.

PY - 2021/5/28

Y1 - 2021/5/28

UR - https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.2012

U2 - 10.1200/JCO.2021.39.15_SUPPL.2012

DO - 10.1200/JCO.2021.39.15_SUPPL.2012

M3 - Article

VL - 39

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Serial plasma and CSF cell-free tumor DNA (cf-tDNA) tracking in diffuse midline glioma patients undergoing treatment with ONC201.

Disciplines

Access to Document

Other files and links

Cite this